Home > Healthcare > Medical Devices > Infection Control > Reprocessed Medical Devices Market
Reprocessed Medical Devices Market size was worth over USD 2 billion in 2022 and is estimated to record 16.9% CAGR from 2023 to 2032 attributed to the presence of favorable regulatory landscape associated with sustainable waste disposal methods.
Several favorable policies for sustainable hospital waste disposal systems have been implemented in response to the increasing environmental concerns. The economic and environmental advantages of recycling medical equipment have been acknowledged by several governments and healthcare organizations worldwide. Additionally, multiple government agencies are launching numerous programs to assist the growth of the medical devices sector, further fueling the market expansion. For instance, the National Medical Devices Policy 2023 in India intends to set the medical devices industry on an expedited path of growth with a patient-centric strategy to fulfill the patients' changing healthcare demands.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Reprocessed Medical Devices Market Size in 2022: | USD 2.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 16.9% |
2032 Value Projection: | USD 10.2 billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 220 |
Tables, Charts & Figures: | 499 |
Segments covered: | Product, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The rising concerns of infection and pathogenic agent transmission among patients in healthcare settings caused by reprocessed surgical equipment may hamper the industry growth to some extent. Most surgical site infections (SSI) are brought on by contaminated environments, inappropriate medical equipment reprocessing, and cross-infection in these devices. However, standards and practices for safe reprocessing are specified to eliminate these hazards. Inadequate reprocessing of surgical equipment, such as flexible duodenoscopes and arthroscopic shavers have also resulted in high infection rates, limiting the product adoption.